Record Operating Results; PLO and Revenue reach all-time highs AUSTIN, Texas, May 06, 2026 (GLOBE NEWSWIRE) — EZCORP, Inc. (NASDAQ: EZPW), a leading provider of pawn transactions in the United States, Latin America and the Caribbean, today announced results for its second quarter ended March 31, 2026. Unless otherwise noted, all amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”) and comparisons shown are to the same period in the prior year. SECOND QUARTER HIGHLIGHTSNet income attributable to EZCORP increased 93% to $49.1 million. On an adjusted basis1, net income attributable to EZCORP increased 84% to $46.5 million. Diluted earnings per share (EPS) increased 85% to $0.61. On an adjusted basis1, diluted earnings per share increased 76% to $0.58. Adjusted EBITDA increased 76%...

Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights  A supplemental long‑form earnings release providing additional operational details and business update for Q1 2026 is available at: https://investors.alvotech.com/earnings-calendar under “Q1 2026 Earnings Call”. The supplemental document is provided solely for reference and is not part of this SEC Form 6‑K. The Form 6‑K should not be read together with, or construed as referring to, the supplemental long‑form release. Q1 2026 HighlightsTotal revenues1 were $105.9m compared to $132.8m in the same period last year Adjusted EBITDA1 was $24.4m with Gross Margin of 57%Post-period end:Submitted a Marketing Authorization Application to the European Medicines Agency for AVT16 and AVT80, proposed biosimilars to Entyvio® (vedolizumab)Commenced a pivotal...

REYKJAVIK, Iceland, May 06, 2026 (GLOBE NEWSWIRE) — Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights  A supplemental long‑form earnings release providing additional operational details and business update for Q1 2026 is available at: https://investors.alvotech.com/earnings-calendar under “Q1 2026 Earnings Call”. The supplemental document is provided solely for reference and is not part of this SEC Form 6‑K. The Form 6‑K should not be read together with, or construed as referring to, the supplemental long‑form release. Q1 2026 HighlightsTotal revenues1 were $105.9m compared to $132.8m in the same period last year Adjusted EBITDA1 was $24.4m with Gross Margin of 57% Post-period end: Submitted a Marketing Authorization Application to the European Medicines Agency for AVT16 and AVT80, proposed...

Dallas, Texas, May 06, 2026 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported net income attributable to NL stockholders of $4.3 million, or $.09 per share, in the first quarter of 2026 compared to $.7 million, or $.01 per share, in the first quarter of 2025. NL’s results include an unrealized gain of $2.7 million in the first quarter of 2026 compared to an $8.5 million unrealized loss in the first quarter of 2025 related to the change in value of marketable equity securities. CompX’s net sales were $40.6 million in the first quarter of 2026 compared to $40.3 million in the first quarter of 2025.  CompX’s first quarter 2026 net sales increased over the comparable 2025 period due to higher Marine Components sales to the industrial market partially offset by lower Security Products sales. CompX’s segment profit increased...

Phase 1a interim data for ongoing CTIM-76 (CLDN6 x CD3) trial expected in June 2026 Phase 1a interim data for ongoing CT-95 (MSLN x CD3) trial expected in September 2026 Phase 1 initiation for CT-202 (Nectin-4 x CD3) trial expected in third quarter of 2026 Cash and cash equivalents of $54.5 million as of March 31, 2026 expected to fund operations into mid-2027 PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging (“TCE”) bispecific antibodies for solid tumors, today announced its financial results for the first quarter ended March 31, 2026, and reported on recent and upcoming business highlights. “We continue to execute across our pipeline and believe we are making meaningful scientific and operational...

Declares Dividend of $0.35 per Share for Q1 2026, Marking 133% Increase Year-Over-Year and 27th Consecutive Quarterly Dividend Expects Significantly Higher Q2 2026 Dividend High Specification Scrubber-Fitted Capesize Vessel Expected to Deliver in Q2 2026, Further Enhancing Earnings Power and Dividend Capacity NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) — Genco Shipping & Trading Limited (NYSE:GNK) (“Genco” or the “Company”), the largest U.S. headquartered drybulk shipowner focused on the global transportation of commodities, today reported its financial results for the three months ended March 31, 2026. First Quarter 2026 and Year-to-Date HighlightsDividendDeclared a $0.35 per share dividend for Q1 2026, 133% higher than Q1 2025 27th consecutive quarterly dividendCumulative dividends of $7.915 per share or approximately...

Diversified Energy Company (“Diversified”, “DEC”, or the “Company”) (NYSE: DEC, LSE: DEC) is pleased to announce its financial and operational results for the three months ended March 31, 2026. First Quarter and Recent HighlightsCamino Natural Resources Acquisition: Innovative Carlyle acquisition financing structure utilized for joint acquisition of $1.175B Oklahoma asset, further expanding the Company’s leading Oklahoma operations Closing of Sheridan Acquisition: Acquisition closed on April 30th, adding ~62 MMcfepd of production and ~$52M of NTM EBITDA contiguous to our portfolio of assets in East Texas Shareholder Returns: Returned $94M to shareholders in 1Q26, including $72M in share repurchases in conjunction with the full exit of EIG, the former primary owner of Maverick Natural Resources Portfolio...